Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701K Sell
29,095
-1,632
-5% -$42.7K 0.16% 112
2026
Q1
$863K Buy
30,727
+844
+3% +$22.5K 0.22% 88
2025
Q4
$744K Sell
29,883
-164
-0.5% -$4.14K 0.2% 94
2025
Q3
$766K Buy
30,047
+1,346
+5% +$33.2K 0.22% 90
2025
Q2
$696K Buy
28,701
+5,700
+25% +$133K 0.22% 94
2025
Q1
$583K Buy
23,001
+435
+2% +$11.4K 0.19% 110
2024
Q4
$599K Sell
22,566
-19,548
-46% -$530K 0.21% 99
2024
Q3
$1.22M Sell
42,114
-300
-0.7% -$8.75K 0.44% 51
2024
Q2
$1.19M Sell
42,414
-608
-1% -$16.7K 0.48% 48
2024
Q1
$1.19M Buy
43,022
+7,255
+20% +$201K 0.53% 44
2023
Q4
$1.03M Sell
35,767
-7,200
-17% -$218K 0.52% 50
2023
Q3
$1.43M Sell
42,967
-865
-2% -$30.6K 0.79% 32
2023
Q2
$1.61M Sell
43,832
-1,000
-2% -$38.9K 0.87% 28
2023
Q1
$1.83M Buy
44,832
+24,831
+124% +$1.07M 1.05% 21
2022
Q4
$1.02M Sell
20,001
-154
-0.8% -$7.38K 0.63% 43
2022
Q3
$882K Sell
20,155
-192
-0.9% -$9.33K 0.62% 42
2022
Q2
$1.07M Buy
20,347
+100
+0.5% +$5.1K 0.74% 31
2022
Q1
$1.05M Sell
20,247
-451
-2% -$23.4K 0.63% 39
2021
Q4
$1.22M Buy
+20,698
New +$1.03M 0.75% 29

Other funds holding PFE

City State Bank's PFE Position: Q2 2026 in Review

City State Bank reduced its Pfizer (PFE) stake by 5.3% in Q2 2026, selling an estimated $42.7K and leaving 29,095 shares worth $701K. The position accounts for 0.16% of the portfolio, ranked #112.

City State Bank first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.83M in Q1 2023. 1,259 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • City State Bank held 29,095 shares of Pfizer worth $701K as of Q2 2026.
  • City State Bank sold 1,632 Pfizer shares in Q2 2026, an estimated $42.7K.
  • Pfizer made up 0.16% of City State Bank's portfolio in Q2 2026, its #112 holding.
  • City State Bank first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • City State Bank's Pfizer position peaked at $1.83M in Q1 2023.
  • 1,259 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.